Form 10-Q Opexa Therapeutics, Inc. For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Opexa Therapeutics (OPXA) Tops Q1 EPS by 4c
May 12, 2016 4:57 PM EDTOpexa Therapeutics (NASDAQ: OPXA) reported Q1 EPS of ($0.31), $0.04 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $726.3 thousand versus the consensus estimate of $400 thousand.
Financial Guidance
Based on the current activities of the Company and projected... More
